Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Haohai Biological Technology Co., Ltd. announced successful shareholder meetings where all proposed resolutions, including the 2024 Interim Profit Distribution Plan, were passed by a significant majority. The meetings saw strong shareholder participation with over 66% of voting shares represented at the EGM and majorities of over 76% and 17% for A and H Shares respectively in their class meetings. The company confirmed the approval of amendments to management rules for related party transactions and external guarantees, which received near-unanimous support.
For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.